De Novo device
Accelerate Pheno system, Accelerate Phenotest BC Kit
Accelerate Diagnotics · Positive Blood Culture Identification And Ast Kit (PRH, Class II) · First FDA decision Feb 23, 2017, newest Feb 23, 2017Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
2
Naming "Accelerate Pheno"
MAUDE reports
0
Brand "Accelerate Pheno", since 2015
PubMed studies
51
Mentioning "Accelerate Pheno"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Accelerate Pheno system, Accelerate Phenotest BC Kit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Accelerate Pheno", any status and sponsor, newest update first.
Accelerate Diagnostics, Inc.Not on our public-company list
NCT04295915 · 731 participants · Start Mar 11, 2020 · Primary completion Dec 2, 2021
Device: Specimens that meet inclusion criteria · For: Bacteremia
Sites: Tucson, Arizona; Hershey, Pennsylvania; Lewisville, Texas
- Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative BacteremiaPivotal-lookingCompleted
Duke UniversityAcademic, hospital or other
NCT03218397 · 500 participants · Start Oct 9, 2017 · Primary completion Nov 3, 2018
Device: Accelerate PhenoTest™ BC Kit; Standard Culture and AST · For: Gram-negative Bacteremia
Sites: Los Angeles, California; Rochester, Minnesota
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Accelerate Pheno", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PRH
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Accelerate Pheno"[tiab]. The summary above synthesizes these.
- Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis.
Liborio MP, Harris PNA, Ravi C, et al. · Microorganisms · 2024Review
- Accelerate Phenoࡊ blood culture detection system: a literature review.
Cenci E, Paggi R, Socio GV, et al. · Future Microbiol · 2020Review
- The Accelerate Phenoࡊ System-A New Tool in Microbiological Diagnostics of Bloodstream Infections: A Pilot Study from Poland.
Zalas-Wiwcek P, Bogiel T, Gospodarek-Komkowska E · Pathogens · 2022
- Combination of a Rapid Diagnostic Assay and Antimicrobial Stewardship Intervention for Gram-Negative Bacteremia.
Ventres JJ, Ting MH, Parente DM, et al. · Open Forum Infect Dis · 2024
- Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes.
Ligero-López J, Falces-Romero I, Aranda-Díaz A, et al. · Rev Esp Quimioter · 2024
- Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
Babowicz F, LaPlante R, Mitchell C, et al. · Antimicrob Agents Chemother · 2021
- Accelerate Phenoࡊ system in sepsis by Gram-negative pathogens: four months of hospital experience.
De Socio GV, Belati A, Paggi R, et al. · New Microbiol · 2020
- Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.
Lutgring JD, Bittencourt C, McElvania TeKippe E, et al. · J Clin Microbiol · 2018Evaluation Study
- Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients.
Dare RK, Lusardi K, Pearson C, et al. · Clin Infect Dis · 2021
- Rapid and Simple Approaches for Diagnosis of Staphylococcus aureus in Bloodstream Infections.
Duan R, Wang P · Pol J Microbiol · 2022Review
- Effective implementation of the Accelerate Phenoࡊ system for positive blood cultures.
Humphries R, Di Martino T · J Antimicrob Chemother · 2019
- Performance of the Accelerate Diagnostics PhenoTM system with resin-containing BacT/ALERT® Plus blood culture bottles.
Starr KF, Robinson DC, Hazen KC · Diagn Microbiol Infect Dis · 2019Evaluation Study
Other devices of this type
Also filed under product code PRH.
- Accelerate Pheno System, Accelerate PhenoTest BC KitAccelerate Diagnostics, Inc. · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.